Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 AAV
1.2.3 Adenoviral
1.2.4 Lentiviral
1.2.5 Retroviral
1.2.6 Plasmid DNA
1.2.7 Other Vectors
1.3 Market by Application
1.3.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Perspective (2018-2033)
2.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Growth Trends by Region
2.2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Size by Region (2018-2023)
2.2.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Region (2024-2033)
2.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Dynamics
2.3.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Industry Trends
2.3.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Drivers
2.3.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Challenges
2.3.4 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Revenue
3.1.1 Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Revenue (2018-2023)
3.1.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Players (2018-2023)
3.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue
3.4 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in 2022
3.5 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Key Players Head office and Area Served
3.6 Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Solution and Service
3.7 Date of Enter into Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Breakdown Data by Type
4.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Size by Type (2018-2023)
4.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Type (2024-2033)
5 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Breakdown Data by Application
5.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Size by Application (2018-2023)
5.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2018-2033)
6.2 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2018-2023)
6.4 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2018-2033)
7.2 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2018-2023)
7.4 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2018-2033)
8.2 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2018-2023)
8.4 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2018-2033)
9.2 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2018-2023)
9.4 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2018-2033)
10.2 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2018-2023)
10.4 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Detail
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.1.4 BioReliance Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Detail
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.2.4 Cobra Biologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.4.4 UniQure Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Detail
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.5.4 FinVector Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Detail
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.6.4 MolMed Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Detail
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.7.4 MassBiologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.7.5 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Detail
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.8.4 Richter-Helm Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.8.5 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.10.4 Lonza Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.10.5 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Detail
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.11.4 Aldevron Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Detail
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.12.4 Eurogentec Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Detail
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.14.4 Biovian Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.14.5 Biovian Recent Development
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Detail
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.16 VGXI
11.16.1 VGXI Company Detail
11.16.2 VGXI Business Overview
11.16.3 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.16.4 VGXI Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.16.5 VGXI Recent Development
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Detail
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.17.4 PlasmidFactory Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.17.5 PlasmidFactory Recent Development
11.18 bluebird bio
11.18.1 bluebird bio Company Detail
11.18.2 bluebird bio Business Overview
11.18.3 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.18.4 bluebird bio Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.18.5 bluebird bio Recent Development
11.19 Novasep
11.19.1 Novasep Company Detail
11.19.2 Novasep Business Overview
11.19.3 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.19.4 Novasep Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.19.5 Novasep Recent Development
11.20 Spark Therapeutics
11.20.1 Spark Therapeutics Company Detail
11.20.2 Spark Therapeutics Business Overview
11.20.3 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.20.4 Spark Therapeutics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.20.5 Spark Therapeutics Recent Development
11.21 Vigene Biosciences
11.21.1 Vigene Biosciences Company Detail
11.21.2 Vigene Biosciences Business Overview
11.21.3 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.21.4 Vigene Biosciences Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
11.21.5 Vigene Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of AAV
Table 3. Key Players of Adenoviral
Table 4. Key Players of Lentiviral
Table 5. Key Players of Retroviral
Table 6. Key Players of Plasmid DNA
Table 7. Key Players of Other Vectors
Table 8. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Region (2018-2023)
Table 12. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Region (2024-2033)
Table 14. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Trends
Table 15. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Drivers
Table 16. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Challenges
Table 17. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Restraints
Table 18. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Players (2018-2023)
Table 20. Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing as of 2022)
Table 21. Ranking of Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Solution and Service
Table 25. Date of Enter into Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2018-2023)
Table 29. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2024-2033)
Table 31. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2018-2023)
Table 33. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2024-2033)
Table 35. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 50. BioReliance Company Detail
Table 51. BioReliance Business Overview
Table 52. BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 53. BioReliance Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 54. BioReliance Recent Development
Table 55. Cobra Biologics Company Detail
Table 56. Cobra Biologics Business Overview
Table 57. Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 58. Cobra Biologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 59. Cobra Biologics Recent Development
Table 60. Oxford BioMedica Company Detail
Table 61. Oxford BioMedica Business Overview
Table 62. Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 63. Oxford BioMedica Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 64. Oxford BioMedica Recent Development
Table 65. UniQure Company Detail
Table 66. UniQure Business Overview
Table 67. UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 68. UniQure Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 69. UniQure Recent Development
Table 70. FinVector Company Detail
Table 71. FinVector Business Overview
Table 72. FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 73. FinVector Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 74. FinVector Recent Development
Table 75. MolMed Company Detail
Table 76. MolMed Business Overview
Table 77. MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 78. MolMed Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 79. MolMed Recent Development
Table 80. MassBiologics Company Detail
Table 81. MassBiologics Business Overview
Table 82. MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 83. MassBiologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 84. MassBiologics Recent Development
Table 85. Richter-Helm Company Detail
Table 86. Richter-Helm Business Overview
Table 87. Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 88. Richter-Helm Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 89. Richter-Helm Recent Development
Table 90. FUJIFILM Diosynth Biotechnologies Company Detail
Table 91. FUJIFILM Diosynth Biotechnologies Business Overview
Table 92. FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 93. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 94. FUJIFILM Diosynth Biotechnologies Recent Development
Table 95. Lonza Company Detail
Table 96. Lonza Business Overview
Table 97. Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 98. Lonza Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 99. Lonza Recent Development
Table 100. Aldevron Company Detail
Table 101. Aldevron Business Overview
Table 102. Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 103. Aldevron Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 104. Aldevron Recent Development
Table 105. Eurogentec Company Detail
Table 106. Eurogentec Business Overview
Table 107. Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 108. Eurogentec Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 109. Eurogentec Recent Development
Table 110. Cell and Gene Therapy Catapult Company Detail
Table 111. Cell and Gene Therapy Catapult Business Overview
Table 112. Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 113. Cell and Gene Therapy Catapult Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 114. Cell and Gene Therapy Catapult Recent Development
Table 115. Biovian Company Detail
Table 116. Biovian Business Overview
Table 117. Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 118. Biovian Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 119. Biovian Recent Development
Table 120. Thermo Fisher Scientific (Brammer Bio) Company Detail
Table 121. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 122. Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 123. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 124. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 125. VGXI Company Detail
Table 126. VGXI Business Overview
Table 127. VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 128. VGXI Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 129. VGXI Recent Development
Table 130. PlasmidFactory Company Detail
Table 131. PlasmidFactory Business Overview
Table 132. PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 133. PlasmidFactory Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 134. PlasmidFactory Recent Development
Table 135. bluebird bio Company Detail
Table 136. bluebird bio Business Overview
Table 137. bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 138. bluebird bio Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 139. bluebird bio Recent Development
Table 140. Novasep Company Detail
Table 141. Novasep Business Overview
Table 142. Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 143. Novasep Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 144. Novasep Recent Development
Table 145. Spark Therapeutics Company Detail
Table 146. Spark Therapeutics Business Overview
Table 147. Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 148. Spark Therapeutics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 149. Spark Therapeutics Recent Development
Table 150. Vigene Biosciences Company Detail
Table 151. Vigene Biosciences Business Overview
Table 152. Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 153. Vigene Biosciences Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 154. Vigene Biosciences Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type: 2022 VS 2033
Figure 3. AAV Features
Figure 4. Adenoviral Features
Figure 5. Lentiviral Features
Figure 6. Retroviral Features
Figure 7. Plasmid DNA Features
Figure 8. Other Vectors Features
Figure 9. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application: 2022 VS 2033
Figure 11. Cancers Case Studies
Figure 12. Inherited Disorders Case Studies
Figure 13. Viral Infections Case Studies
Figure 14. Others Case Studies
Figure 15. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Report Years Considered
Figure 16. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Region: 2022 VS 2033
Figure 19. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Players in 2022
Figure 20. Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in 2022
Figure 22. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2018-2033)
Figure 24. United States Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2018-2033)
Figure 28. Germany Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Region (2018-2033)
Figure 36. China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2018-2033)
Figure 44. Mexico Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2018-2033)
Figure 48. Turkey Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. BioReliance Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 51. Cobra Biologics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 52. Oxford BioMedica Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 53. UniQure Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 54. FinVector Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 55. MolMed Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 56. MassBiologics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 57. Richter-Helm Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 58. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 59. Lonza Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 60. Aldevron Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 61. Eurogentec Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 62. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 63. Biovian Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 64. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 65. VGXI Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 66. PlasmidFactory Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 67. bluebird bio Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 68. Novasep Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 69. Spark Therapeutics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 70. Vigene Biosciences Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed